Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Colorcon
Johnson and Johnson
McKinsey
Harvard Business School

Last Updated: January 26, 2023

CLINICAL TRIALS PROFILE FOR LESINURAD


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Lesinurad

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01493531 ↗ Combining Lesinurad With Allopurinol in Inadequate Responders Completed Ardea Biosciences, Inc. Phase 3 2011-12-01 This study will compare the serum uric acid lowering effects, clinical benefits, and safety of lesinurad in combination with allopurinol to allopurinol alone in subjects with gout who have had an inadequate response to allopurinol.
NCT01508702 ↗ Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors Completed Ardea Biosciences, Inc. Phase 3 2012-01-01 This study will assess the serum uric acid lowering effects and safety of lesinurad compared to placebo in patients who are intolerant or have a contraindication to allopurinol or febuxostat.
NCT01510158 ↗ Combining Lesinurad With Allopurinol in Inadequate Responders Completed Ardea Biosciences, Inc. Phase 3 2012-01-01 This study that compare the serum uric acid lowering effects, clinical benefits, and safety of lesinurad in combination with allopurinol to allopurinol alone in subjects with gout who have had an inadequate response to allopurinol.
NCT01510769 ↗ Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat Completed Ardea Biosciences, Inc. Phase 3 2012-01-01 This study will compare the serum uric acid lowering effects, clinical benefits, and safety of lesinurad in combination with febuxostat to febuxostat alone in patients with tophaceaous gout.
NCT01650246 ↗ Open-Label Lesinurad Monotherapy Extension Study in Gout Completed Ardea Biosciences, Inc. Phase 3 2012-08-01 This study will assess the serum uric acid lowering effects and safety of lesinurad over a long-term timeframe.
NCT01744379 ↗ Single and Multiple Dose Study in Japanese Completed Ardea Biosciences, Inc. Phase 1 2012-12-01 This study will explore the safety, tolerability, and serum uric acid lowering effect of lesinurad in healthy Japanese males to allow comparison with the Western population.
NCT01808131 ↗ Lesinurad and Allopurinol Combination Extension Study in Gout Completed Ardea Biosciences, Inc. Phase 3 2013-02-01 This study will assess the serum uric acid lowering effects and safety of lesinurad in combination with allopurinol over a long-term timeframe.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lesinurad

Condition Name

Condition Name for Lesinurad
Intervention Trials
Gout 10
Healthy 8
Chronic Kidney Disease (CKD) 1
Tophaceous Gout 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Lesinurad
Intervention Trials
Gout 8
Renal Insufficiency, Chronic 1
Kidney Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Lesinurad

Trials by Country

Trials by Country for Lesinurad
Location Trials
United States 257
Canada 20
Poland 20
Australia 20
New Zealand 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Lesinurad
Location Trials
Michigan 11
Texas 11
California 11
Tennessee 8
New York 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Lesinurad

Clinical Trial Phase

Clinical Trial Phase for Lesinurad
Clinical Trial Phase Trials
Phase 4 1
Phase 3 7
Phase 1 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Lesinurad
Clinical Trial Phase Trials
Completed 18
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Lesinurad

Sponsor Name

Sponsor Name for Lesinurad
Sponsor Trials
Ardea Biosciences, Inc. 18
Medpace, Inc. 1
Ironwood Pharmaceuticals, Inc. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Lesinurad
Sponsor Trials
Industry 20
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Mallinckrodt
Merck
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.